FADS1 Antibodies

Santa Cruz Biotechnology provides a broad selection of FADS1 monoclonal antibodies for research in lipid metabolism and fatty acid synthesis. FADS1 Antibodies for FADS1 are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FADS1, or fatty acid desaturase 1, plays a crucial role in the conversion of saturated fatty acids to unsaturated fatty acids, which is essential for maintaining membrane fluidity and function. FADS1 significantly influences lipid profiles and has implications in metabolic disorders, cardiovascular diseases, and inflammation. Understanding FADS1 function can provide insights into therapeutic targets for various health conditions. Research into FADS1 continues to reveal new connections between lipid metabolism and human health. Investigating FADS1 activity helps scientists better understand cellular membrane composition and its impact on disease progression. Current studies focusing on FADS1 are uncovering potential therapeutic strategies for metabolic and cardiovascular conditions. Santa Cruz Biotechnology monoclonal antibodies for FADS1 support researchers worldwide in advancing our understanding of lipid biology and its role in human health.